Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma - Scorecard - MDSpire

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma

  • By

  • Hui Wang

  • Jun Li

  • Yinghai Wang

  • Yuebin Shi

  • Peiren Tang

  • Ying Li

  • Jiang Gu

  • Li Wang

  • June 18, 2026

  • 0 min

Share

Clinical Scorecard: Investigation of IgG1/IgG4 Glycosylation Patterns and Monocyte-Derived Dendritic Cell Activity in Esophageal Squamous Cell Carcinoma

At a Glance

CategoryDetail
Condition
Key MechanismsExpand to include clinical implications of IgG4's immunosuppressive functions in ESCC.
Target Population
Care Setting

Key Highlights

  • highlight_5

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • t
    • h
    • e
    • r
    • a
    • p
    • e
    • u
    • t
    • i
    • c
    • s
    • t
    • r
    • a
    • t
    • e
    • g
    • i
    • e
    • s
    • t
    • h
    • a
    • t
    • c
    • o
    • u
    • l
    • d
    • b
    • e
    • e
    • x
    • p
    • l
    • o
    • r
    • e
    • d
    • b
    • a
    • s
    • e
    • d
    • o
    • n
    • I
    • g
    • G
    • 4
    • '
    • s
    • r
    • o
    • l
    • e
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Detail how IgG4's properties may affect specific immunotherapy approaches.

        Clinical Best Practices

        • best_practice_1

        Related Resources & Content

        Original Source(s)

        Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma

        • by Hui Wang, Jun Li, Yinghai Wang, Yuebin Shi, Peiren Tang, Ying Li, Jiang Gu, Li Wang

        • June 18, 2026

        Related Content

        PIGL promotes the docetaxel resistance of prostate cancer and is regulated by E3 ubiquitin ligase HUWE1

        The regulatory roles of dysregulated lactate dehydrogenase A in anti-tumor immunity within immune cells

        Homologous recombination pathway alterations in basal-like breast cancer